5+

The U.S. Pharmacopeial Convention (USP) is a scientific nonprofit organization that sets standards for the identity, strength, quality, and purity of medicines, food ingredients, and dietary supplements manufactured, distributed and consumed worldwide. USP’s drug standards are enforceable in the United States by the Food and Drug Administration, and these standards are used in more than 140 countries.

Post: Senior Analyst/ Analyst - Market Intelligence and Analysis

For more than 20 years, as Albany Molecular Research Inc. (AMRI), we have provided fully integrated drug discovery, development and manufacturing services – all while adapting to the rapidly changing needs of our customers within the pharmaceutical, biotechnology and related industries.
With locations in the United States, Europe and Asia, AMRI SMARTSOURCING™ offers you a versatile and strategic way of partnering with us that is designed to deliver reduced risk, greater flexibility and a better return on investment. AMRI has successfully partnered R&D programs and is actively seeking to out-license its remaining programs for further development.

Post: Research Scientist - Analytical - (1000162)

Shilpa Medicare Ltd. SEZ-Formulation Unit, we are among the fastest growing oncology formulation pharmaceutical company, looking for dynamic young energetic, creative and talented mate candidates for formulation unit at Jadcherla near Hyderabad

IDPL is the largest Central Pharma Public Sector Undertaking in India with plants at Rishikesh, Gurgaon & Hyderabad and two Subsidiary Units at Chennai and Muzaffarpur.
The vision of first Prime Minister of India, Late Pt. Jawahar Lal Nehru regarding Indian Drug Industry was that “the drug industry must be in the public sector….. I think an industry of the nature of the drug industry should not be in the private sector anyhow. There are for too much exploitation of the public in this industry”. With the vision of the then Prime Minister of India, IDPL was incorporated in April, 1961 (Company Registration No. 3418 of 1961-1962 with Registrar of Companies, Delhi and having its Registered and Corporate Office at Gurgaon) with main objectives of creating self-sufficiency in respect of essential life saving medicines, to free the country from dependence on imports and to provide medicines to the millions at affordable prices and not to make millions from the medicines. IDPL was basically conceived and established as a part of Healthcare Infrastructure and has played a pioneering infra-structural role in the growth of Indian Drug Industry base.

At UnitedHealth Group, their mission is to help people live healthier lives. To achieve this goal, they are focused on building a modern, adaptable, innovative and inclusive system of health care services.
Their scale and potential to improve health makes them one of the most visible stewards of America’s vast health care system. Entrusted with both important resources and responsibilities, they are involved on a daily basis in decision-making that has life-changing consequences for millions of Americans.

Post: Associate Director - Healthcare

KPMG international operates as a network of member firms offering audit, tax and advisory services. We work closely with our clients, helping them to mitigate risks and grasp opportunities. Member firms' clients include business corporations, governments and public sector agencies and not-for-profit organizations. They look to KPMG for a consistent standard of service based on high order professional capabilities, industry insight and local knowledge.

TOSC International Pvt. Ltd. is one of the leading Pharmaceutical Companies in India, since 1985. With two manufacturing units in – Delhi and in the Excise free zone of Pantnagar (Rudrapur), we manufacture and supply a wide Therapeutic mix of products in the form of Tablets, Ointments, Syrups, Capsules, Nutraceuicals(Food Products), Injectables, Eye/Ear drops. The company has steadily made progress by successfully earning a reputed name among the Pharmaceutical Companies in India.

Post:  QC Executive-04

Caplin Point Laboratories Ltd generate over US$50 million in revenue annually with a healthy bottom line. We have recently been selected by Forbes Asia magazine as one of the Top 200 best performing companies in Asia, for the second time in a row. Caplin is the only Pharma company in India to be selected in both 2014 and 2015. We have been manufacturing, exporting and distributing our products to Latin America and Africa for the last 16 years and we're already in the Top 5 exporters from India to Latin America over the last few years. We are currently holding over 2000 product licenses in these regions with another 490 in the pipeline. Our latest Injectable facility in Gummidipoondi, built with a budget of HOcr has been funded entirely from internal accruals. The injectable factory has been approved by European Union and Brazil, with US FDA inspection likely to take place by 2016 last quarter.